Nutex Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nutex Health Inc. (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system, has announced that its Founder, Chairman, and CEO, Thomas Vo, M.D., MBA, and President, Warren Hosseinion, M.D., will be participating in the 43rd Annual J.P. Morgan Healthcare Conference. The event will take place on January 10 and 11, 2024, in San Francisco, California.

Nutex Health Presentation Details:
Date: Thursday, January 11, 2024
Time: 9:00 AM – 9:40 AM Pacific Time
Venue: Westin St. Francis Hotel in San Francisco

In addition to the formal presentation, Company management will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.

Nutex Health Inc. is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops, and operates innovative healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in 8 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), Nutex Health provides management, administrative, and other support services to its affiliated hospitals and physician groups. The company's cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems, and sources to create a holistic view of patients and providers, allowing it to deliver greater quality care more efficiently.

Forward-Looking Statements:
Certain statements and information included in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will”, “will likely result,” “expected to,” “expects to,” “will continue,” “anticipated,” “estimate,” “projected,” “intend,” “goal,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including final rules implemented under the No Surprises Act and related regulatory guidance, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company’s ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-Q for the period ended September 30, 2023 under the heading “Risk Factors” in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company’s financial performance and could cause the Company’s actual results for future periods to differ materially from any opinions or statements expressed within this press release.




Nutex Health's expansion into new markets and services is expected to have a positive impact on its revenue growth and market share. The company has been expanding its micro-hospital model, which has been gaining traction and showing improvements in both outpatient and inpatient volumes. This expansion is reflected in the company's financial results, with total patient visits growing to 122,944, up 19.6% year-over-year (YoY) as of the first nine months of 2024. Additionally, the company's mature hospitals (opened before 2022) showed healthy growth with a 13.5% revenue increase YTD, while four new hospitals opened in 2023 are ramping up successfully. This expansion into new markets and services is likely to contribute to the company's revenue growth and increase its market share.

The micro-hospital model's lower capital investment and operating costs impact Nutex Health's financial performance compared to traditional hospitals. The company's micro hospitals require less capital investment than traditional hospitals, allowing Nutex Health to expand its network more rapidly and with less financial strain. This lower capital investment allows Nutex Health to achieve faster revenue growth, improved profitability, and increased cash flow compared to traditional hospitals. In the first nine months of 2024, Nutex Health's Hospital Division operating income increased by 159% to $54.7 million compared to the same period in 2023. Additionally, the company's net cash from operating activities was $23.1 million for the first nine months of 2024.

The micro-hospital model's focus on outpatient services and preventive care affects patient outcomes and satisfaction compared to traditional hospitals. By emphasizing outpatient services and preventive care, Nutex Health can provide more personalized and efficient care, leading to better patient satisfaction. The company's focus on preventive care can help patients manage chronic conditions better and detect potential health issues early, leading to better patient outcomes. Additionally, the company's data-driven approach allows for more informed decision-making, better care coordination, and improved patient outcomes.

The micro-hospital model's flexibility in location and size contributes to Nutex Health's ability to adapt to changing market demands and patient needs compared to traditional hospitals. The company's micro hospitals can be established in areas with lower population density or where traditional hospitals may not be feasible due to high costs or lack of demand. This flexibility allows Nutex Health to adapt to changing patient volumes and needs by easily scaling up or down the size of the facilities. This adaptability is crucial in responding to fluctuations in demand, such as those experienced during the COVID-19 pandemic.

In conclusion, Nutex Health's expansion into new markets and services, lower capital investment and operating costs, focus on outpatient services and preventive care, and flexibility in location and size contribute to its ability to adapt to changing market demands and patient needs. The company's strong financial performance and expanding footprint reflect its success in implementing these strategies. As Nutex Health continues to grow and innovate, it is well-positioned to capitalize on trends in value-based care and healthcare reform, ultimately delivering greater quality care more efficiently.